The Enterprise Value as of December 2025 (TTM) for Biocon Limited (BIOCON.NS) is 646.83B

According to Biocon Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 646.83B. This represents a change of 13.83% compared to the average of 568.24B of the last 4 quarters.

Biocon Limited (BIOCON.NS) Historical Enterprise Value (quarterly & annually)

How has BIOCON.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Biocon Limited over the last ten years is 384.83B. The current 646.83B Enterprise Value has changed 16.71% with respect to the historical average. Over the past ten years (40 quarters), BIOCON.NS's Enterprise Value was at its highest in in the September 2024 quarter at 593.66B. The Enterprise Value was at its lowest in in the December 2015 quarter at 106.59B.

Biocon Limited (BIOCON.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Biocon Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Biocon Limited (BIOCON.NS) Average Enterprise Value

How has BIOCON.NS Enterprise Value performed in the past?

The current Enterprise Value of Biocon Limited (BIOCON.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Biocon Limited (BIOCON.NS) Enterprise Value vs. Peers

How is BIOCON.NS’s Enterprise Value compared to its peers?

Biocon Limited’s Enterprise Value is greater than Laurus Labs Limited (575.43B), greater than Laurus Labs Limited (575.43B), greater than Glenmark Pharmaceuticals Limited (555.43B), greater than Glenmark Pharmaceuticals Limited (555.43B), greater than GlaxoSmithKline Pharmaceuticals Limited (424.12B), greater than GlaxoSmithKline Pharmaceuticals Limited (424.12B), greater than Syngene International Limited (259.56B), greater than Syngene International Limited (259.56B), greater than Aster DM Healthcare Limited (336.45B), greater than Piramal Pharma Limited (281.25B),

Build a custom stock screener for Biocon Limited (BIOCON.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biocon Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biocon Limited (BIOCON.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biocon Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.